bcbs fep glp-1 coverage 2025 Major insurance changes are coming to drugs for weight loss. Here's how that could affect patients Why we are changing coverage

GLP-1 medicines (like Wegovy and Mounjaro )mimic this hormone

In all reported cases of acromegaly-associated ketoacidosis, diabetes resolved after remission of acromegaly

Inflammation and immune dysfunction in Parkinson disease

In fact, of the nearly half a million adults on GLP-1s, more than 60% consume below estimated requirements for calcium and iron and vitamin D intake averaged just 20% of recommendations, according to a 2026 narrative review in Clinical Obesity

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound